NCT07746570Completed
SU JOK THERAPY TO IMPROVE DYSPNEA AND INSOMNIA IN ASTHMA
THE EFFECT OF SU JOK THERAPY ON DYSPNEA AND INSOMNIA IN PATIENTS WITH ASTHMA: A RANDOMIZED CONTROLLED TRIAL
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
Asthma is a long-term lung disease that can make breathing difficult and can also affect sleep. Even with regular medical treatment, many people with asthma continue to experience shortness of breath and insomnia. This study will examine whether Su Jok therapy, a complementary therapy that applies gentle stimulation to specific points on the hands and feet, can help reduce shortness of breath and improve sleep in people with asthma. Adults with asthma who agree to participate will be randomly assigned to one of two groups. One group will receive Su Jok therapy in addition to their usual care, while the other group will receive usual care only. Researchers will compare changes in breathing difficulty and sleep quality between the two groups. The results of this study may help determine whether Su Jok therapy can be used as a safe and supportive treatment alongside standard asthma care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 31 Jul 2026
- Start date
- 2 Jan 2026
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Erzincan Binali Yildirim Universitesi
- Diseases
- Asthma
- NCT number
- NCT07746570
What you commit to
- Study type: Interventional
- Participants enrolled: 26
- From 2 Jan 2026 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of severe cognitive or psychiatric disorders that could interfere with participation.
- Presence of skin lesions, infection, or injury on the hands that would prevent Su Jok therapy.
Other
- Participation in another clinical trial during the study period.
- Withdrawal of consent at any stage of the study.
Who the study is looking for
- Adults aged 18 years or older.
- Diagnosed with asthma by a physician.
- A baseline Visual Analog Scale (VAS) score of 3 or higher for both dyspnea and insomnia.
- Receiving routine asthma treatment.
- Able to communicate in Turkish.
- Able to understand the study procedures and provide written informed consent.
- Willing to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erzincan Binali Yıldırım University Coordinator of this site? Confirm its status | Erzincan | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.